1. Home
  2. DRCT vs MBAI Comparison

DRCT vs MBAI Comparison

Compare DRCT & MBAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Direct Digital Holdings Inc.

DRCT

Direct Digital Holdings Inc.

HOLD

Current Price

$4.10

Market Cap

8.9M

Sector

Technology

ML Signal

HOLD

Logo Check-Cap Ltd. Ordinary Share

MBAI

Check-Cap Ltd. Ordinary Share

N/A

Current Price

$1.49

Market Cap

10.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DRCT
MBAI
Founded
2018
2004
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
8.9M
10.6M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
DRCT
MBAI
Price
$4.10
$1.49
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$330.00
N/A
AVG Volume (30 Days)
7.2M
23.7K
Earning Date
11-06-2025
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$35,369,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$25.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.58
$0.59
52 Week High
$80.85
$3.13

Technical Indicators

Market Signals
Indicator
DRCT
MBAI
Relative Strength Index (RSI) 90.17 N/A
Support Level $1.58 N/A
Resistance Level $2.98 N/A
Average True Range (ATR) 0.44 0.00
MACD 0.29 0.00
Stochastic Oscillator 70.16 0.00

Price Performance

Historical Comparison
DRCT
MBAI

About DRCT Direct Digital Holdings Inc.

Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.

About MBAI Check-Cap Ltd. Ordinary Share

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

Share on Social Networks: